Purchases and Sales Made in Q3 2024 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q3 2024. The information is specifically focused on institutions that hold shares of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-136K- 67.1% |
$426K - $622K
|
66.9K
$211K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Seas Capital LP
Rye, NY |
SELL
|
- |
-184K- 2.15% |
$575K - $841K
|
8.39M
$26.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-258K- 27.89% |
$806K - $1.18M
|
668K
$2.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-462K- 81.49% |
$1.44M - $2.11M
|
105K
$331K
|
|
|
Nov 13, 2024
Q3 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-655K- 38.87% |
$2.04M - $2.99M
|
1.03M
$3.24M
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-1.03M- 90.45% |
$3.22M - $4.71M
|
109K
$344K
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-1.2M- 36.48% |
$3.74M - $5.47M
|
2.09M
$6.58M
|